See all
 |
Articles: Drug/Product Approvals |
Prior Articles
CryoLife Receives CE Mark Approval for BioFoam Hemostatic Technology
Cryolife, 08/05/09
Free full text
Cerner Mammography Gets FDA OK
HealthDataManagement, 08/05/09 FDA Approves Avastin for the Most Common Type of Kidney Cancer
Genentech, 08/04/09
Free full text
U.s. food and drug administration approves onglyza (saxagliptin) for the treatment of type 2 diabetes mellitus in adults
AstraZeneca, 08/04/09
Free full text
Avastin approved in US for the most common type of kidney cancer
Roche, 08/04/09
Free full text
U.S. Food and Drug Administration Approves ONGLYZA (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults
Bristol Myers-Squibb Company, 08/04/09
Free full text
FDA Approves Expanded Use of ISENTRESS (raltegravir) in Combination Therapy for Adult Patients with HIV-1 Infection to Include Patients Not Previously Treated with HIV Medicines
Merck & Co., 08/03/09
Free full text
FDA Approves INVEGA SUSTENNA for the Acute and Maintenance Treatment of Schizophrenia
Janssen, 08/03/09
Free full text
U.S. Food and Drug Administration Approves ONGLYZA (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults
Bristol Myers-Squibb Company, 08/03/09
Free full text
INVEGA Approved as the First and Only Treatment for Schizoaffective Disorder
Janssen, 08/03/09
Free full text
Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe
Cell Therapeutics, 07/31/09
Free full text
AstraZeneca submits New Drug Applications for ZACTIMA in second-line advanced non-small cell lung cancer
AstraZeneca, 07/31/09
Free full text
Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan
BioMarin, 07/31/09
Free full text
Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe
Cell Therapeutics, 07/30/09
Free full text
European commission approves broader label for Avastin allowing combination with docetaxel for the first-line treatment of advanced (metastatic) breast cancer
Roche, 07/30/09
Free full text
New ACTICOAT Silver Coated Anti-microbial Barrier Dressing
Receives 510 Clearance from the US FDA
Nucryst, 07/30/09
Free full text
Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive
Warner Chilcott, 07/30/09 Warner Chilcott Proposes Redomestication From Bermuda to Ireland
Warner Chilcott, 07/30/09 Taro Receives FDA Approval for Cetirizine Hydrochloride Tablets (OTC) ANDA
Taro Pharmaceuticals USA, 07/29/09
Free full text
Generic omeprazole delayed-release capsules: in vitro performance evaluations
Drug Development and Industrial Pharmacy, 07/27/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
125 Available Pages
|
|